首页|Several factors including ITPA polymorphism influence ribavirin-induced anemia in chronic hepatitis C

Several factors including ITPA polymorphism influence ribavirin-induced anemia in chronic hepatitis C

扫码查看
AIM:To construct formulae for predicting the likelihood of ribavirin-induced anemia in pegylated interferon α plus ribavirin for chronic hepatitis C.METHODS:Five hundred and sixty-one Japanese patients with hepatitis C virus genotype 1b who had received combination treatment were enrolled and assigned randomly to the derivation and confirmatory groups.Single nucleotide polymorphisms at or nearby ITPA were genotyped by real-time detection polymerase chain reaction.Factors influencing significant anemia (hemoglobin concentration < 10.0 g/dL at week 4 of treatment) and significant hemoglobin decline (declining concentrations > 3.0 g/dL at week 4) were analyzed using multiple regression analyses.Prediction formulae were constructed by significantly independent factors.RESULTS:Multivariate analysis for the derivation group identified four independent factors associated with significant hemoglobin decline:hemoglobin decline at week 2 [P =3.29 × 10-17,odds ratio (OR) =7.54(g/dL)],estimated glomerular filtration rate [P =2.16 × 10-4,OR =0.962 (mL/min/1.73 m2)],rs1127354 (P=5.75 x 10-4,OR =10.94) and baseline hemoglobin [P =7.86 x 10-4,OR =1.50 (g/dL)].Using the model constructed by these factors,positive and negative predictive values and predictive accuracy were 79.8%,88.8% and 86.2%,respectively.For the confirmatory group,they were 83.3%,91.0% and 88.3%.These factors were closely correlated with significant anemia.However,the model could not be constructed,because no patients with rs1127354 minor genotype CA/AA had significant anemia.CONCLUSION:Reliable formulae for predicting the likelihood of ribavirin-induced anemia were constructed.Such modeling may be useful in developing individual tailoring and optimization of ribavirin dosage.

Chronic hepatitis C virus infectionRibavirinPegylated interferon αPrediction modelHemolytic anemiaSingle nucleotide polymorphism

Akihito Tsubota、Noritomo Shimada、Hiroshi Abe、Kai Yoshizawa、Rie Agata、Yoko Yumoto、Makiko Ika

展开 >

Institute of Clinical Medicine and Research, The Jikei University School of Medicine, 163-1 Kashiwa-shita, Kashiwa, Chiba 277-8567, Japan

Division of Gastroenterology and Hepatology,Kashiwa Hospital, The Jikei University School of Medicine,163-1 Kashiwa-shita, Kashiwa, Chiba 277-8567, Japan

Department of Gastroenterology, Shinmatsudo Central General Hospital,1-380 Shinmatsudo, Matsudo, Chiba 270-0034, Japan

Division of Gastroenterology and Hepatology, Katsushika Medical Center, The Jikei University School of Medicine, 6-41-2 Aoto, Katsushika-ku, Tokyo 125-8506, Japan

展开 >

2012

世界胃肠病学杂志(英文版)
太原消化病研治中心

世界胃肠病学杂志(英文版)

SCI
影响因子:1.001
ISSN:1007-9327
年,卷(期):2012.18(41)
  • 29